Connection

ABDUL DIWAN to Disease Progression

This is a "connection" page, showing publications ABDUL DIWAN has written about Disease Progression.
Connection Strength

0.094
  1. Nuclear expression of the antiapoptotic protein survivin in malignant melanoma. Cancer. 2006 Mar 01; 106(5):1123-9.
    View in: PubMed
    Score: 0.039
  2. Keratoacanthomatous Changes: Unifying the Histologic Spectrum of Actinic Granuloma. Am J Dermatopathol. 2018 Oct; 40(10):762-766.
    View in: PubMed
    Score: 0.023
  3. Phase II trial of imatinib mesylate in patients with metastatic melanoma. Br J Cancer. 2008 Sep 02; 99(5):734-40.
    View in: PubMed
    Score: 0.012
  4. Decreased expression of retinoid receptors in melanoma: entailment in tumorigenesis and prognosis. Clin Cancer Res. 2007 Aug 15; 13(16):4817-24.
    View in: PubMed
    Score: 0.011
  5. Galectin-3 expression is associated with tumor progression and pattern of sun exposure in melanoma. Clin Cancer Res. 2006 Nov 15; 12(22):6709-15.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.